Posts

As our nation attempts to pick itself up and walk away from the COVID battlefield, we can see the toll it has suffered. COVID spurred a pervasive physical and mental health crisis in the United States, but it has also precipitated a financial and operational crisis among our most important healthcare institutions.

End-to-end vector manufacturing optimizes batch success and delivers more doses at lower cost.

The COVID-19 pandemic compelled the industry to re-examine the way it conducted clinical trials, engaged with patients, and promoted to HCPs. Companies began to explore decentralized clinical trials, new non-personal promotion strategies, virtual customer engagement strategies, and new ways to engage with the patient — all with an eye toward replacing status quo processes and technologies. The result was the accelerated development of new clinical and commercial technologies and data with the ultimate goal of bringing new therapies to patients faster.

Part III: Leaders in healthcare marketing and communications explain where technology will have the most impact on the industry.

Even as their clients are trying to make clinical trials more diverse and equitable, agencies are continuing their DE&I efforts to build a culture where diverse talent is welcomed.

Besides reducing the burden of participation, sponsors benefit from lower costs and faster timelines. In addition, when patients are more engaged, patient protocol compliance increases.

The Medical Advertising Hall of Fame honored 2019 inductees Carol DiSanto and Charlene Prounis on Feb. 7th at The Pierre in New York City.

The threatened “pharma marketing tax” may be back in play during 2019, at both the federal and state levels.

The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.

The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.